252 related articles for article (PubMed ID: 9075745)
21. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).
Sauer R; Fietkau R; Wittekind C; Martus P; Rödel C; Hohenberger W; Jatzko G; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R
Strahlenther Onkol; 2001 Apr; 177(4):173-81. PubMed ID: 11370551
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy.
Feliu J; Calvilio J; Escribano A; de Castro J; Sánchez ME; Mata A; Espinosa E; García Grande A; Mateo A; González Barón M
Ann Oncol; 2002 May; 13(5):730-6. PubMed ID: 12075741
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
J Clin Oncol; 1992 Jan; 10(1):79-84. PubMed ID: 1727928
[TBL] [Abstract][Full Text] [Related]
24. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02.
Wolmark N; Wieand HS; Hyams DM; Colangelo L; Dimitrov NV; Romond EH; Wexler M; Prager D; Cruz AB; Gordon PH; Petrelli NJ; Deutsch M; Mamounas E; Wickerham DL; Fisher ER; Rockette H; Fisher B
J Natl Cancer Inst; 2000 Mar; 92(5):388-96. PubMed ID: 10699069
[TBL] [Abstract][Full Text] [Related]
25. Does preoperative radiotherapy with postoperative chemotherapy increase acute side-effects and postoperative complications of total mesorectal excision? Report of the randomized Finnish rectal cancer trial.
Salmenkylä S; Kouri M; Österlund P; Pukkala E; Luukkonen P; Hyöty M; Pääkkönen M; Mäkelä J; Mustonen H; Järvinen HJ;
Scand J Surg; 2012; 101(4):275-82. PubMed ID: 23238504
[TBL] [Abstract][Full Text] [Related]
26. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
27. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
[TBL] [Abstract][Full Text] [Related]
28. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
[TBL] [Abstract][Full Text] [Related]
29. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum.
Rullier E; Goffre B; Bonnel C; Zerbib F; Caudry M; Saric J
Ann Surg; 2001 Nov; 234(5):633-40. PubMed ID: 11685026
[TBL] [Abstract][Full Text] [Related]
30. Preoperative radio-chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group.
Cambray i Amenós M; Navarro García M; Martí Ragué J; Pareja Fernández L; Pera Fábregas J
Clin Transl Oncol; 2007 Mar; 9(3):183-91. PubMed ID: 17403630
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy with preoperative radiotherapy in rectal cancer.
Bosset JF; Collette L; Calais G; Mineur L; Maingon P; Radosevic-Jelic L; Daban A; Bardet E; Beny A; Ollier JC;
N Engl J Med; 2006 Sep; 355(11):1114-23. PubMed ID: 16971718
[TBL] [Abstract][Full Text] [Related]
32. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum.
Chari RS; Tyler DS; Anscher MS; Russell L; Clary BM; Hathorn J; Seigler HF
Ann Surg; 1995 Jun; 221(6):778-86; discussion 786-7. PubMed ID: 7794081
[TBL] [Abstract][Full Text] [Related]
33. Preoperative concurrent chemotherapy and radiotherapy in rectal cancer patients.
Ch'ang HJ; Jian JJ; Cheng SH; Liu MC; Leu SY; Wang FM; Tsai SY; Tsao MH; Lin HH; Huang AT; Sung JL
J Formos Med Assoc; 1998 Jan; 97(1):32-7. PubMed ID: 9481062
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant treatment in operable stage II and III rectal cancer.
Aurelio P; Claudio C; Paolo M; Pierluigi G; Santina C; Domenico D; Numa C; Vincenzo V; Maurizio C; Fabrizio AI
Tumori; 1995; 81(3 Suppl):109-13. PubMed ID: 7571038
[TBL] [Abstract][Full Text] [Related]
35. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
36. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.
Hoff PM; Janjan N; Saad ED; Skibber J; Crane C; Lassere Y; Cleary KR; Benner S; Randolph J; Abbruzzese JL; Pazdur R
J Clin Oncol; 2000 Oct; 18(20):3529-34. PubMed ID: 11032595
[TBL] [Abstract][Full Text] [Related]
37. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation.
Valentini V; Coco C; Cellini N; Picciocchi A; Genovesi D; Mantini G; Barbaro B; Cogliandolo S; Mattana C; Ambesi-Impiombato F; Tedesco M; Cosimelli M
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1067-75. PubMed ID: 9539561
[TBL] [Abstract][Full Text] [Related]
38. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility.
Dencausse Y; Sturm J; Hartung G; Dietzler P; Edler L; Bambach M; Wojatschek C; Lindemann H; Qeisser W
Onkologie; 2001 Oct; 24(5):476-80. PubMed ID: 11694775
[TBL] [Abstract][Full Text] [Related]
40. Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma.
Stein DE; Mahmoud NN; Anné PR; Rose DG; Isenberg GA; Goldstein SD; Mitchell E; Fry RD
Dis Colon Rectum; 2003 Apr; 46(4):448-53. PubMed ID: 12682535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
